Portfolio company
Turing Biosystems
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Turing Biosystems develops an interpretable artificial intelligence platform and graph database to help pharmaceutical companies and clinicians optimise therapies by analysing multi-omics data.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
One Biosciences
One Biosciences develops an AI-powered single-cell transcriptomic platform to provide functional tumour profiling for oncologists and pharmaceutical companies.
Tolemy Bio
This company develops an AI platform to model and optimise cellular behaviour for biotechnology and pharmaceutical organisations developing advanced therapies.
Biobase
Biobase develops an agentic operating system that normalises and unifies clinical and life sciences data for healthcare institutions and pharmaceutical companies.
Tessel Biosciences
The company develops artificial intelligence models and patient-derived virtual tissues to accelerate drug discovery for pharmaceutical and biotechnology organisations.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
CardiaTec Biosciences
This company develops an artificial intelligence platform to identify cardiovascular drug targets for pharmaceutical providers using large-scale multi-omics data.
Biorelate
This company develops an artificial intelligence platform that curates biomedical data to support drug discovery for pharmaceutical and life sciences organisations.
Cime Therapeutics
The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.
